Walser Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Walser Wealth Management's BMY Position: Q3 2026 in Review
Walser Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2026, buying an estimated $149K and bringing the position to 16,731 shares worth $1.04M. The position accounts for 0.42% of the portfolio, ranked #59.
Walser Wealth Management first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Walser Wealth Management held 16,731 shares of Bristol-Myers Squibb worth $1.04M as of Q3 2026.
- Walser Wealth Management bought 2,350 Bristol-Myers Squibb shares in Q3 2026, an estimated $149K.
- Bristol-Myers Squibb made up 0.42% of Walser Wealth Management's portfolio in Q3 2026, its #59 holding.
- Walser Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Walser Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.